Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study

Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study

Erythroferrone (ERFE) is a hepcidin inhibitor whose synthesis is stimulated by erythropoietin, which increases iron absorption and mobilization. We studied the association between serum ERFE and mortality and non-fatal cardiovascular (CV) events in a cohort of 1123 hemodialysis patients and in a coh...

Full description

Bibliographic Details
Main Authors: Belinda Spoto, Rahul Kakkar, Larry Lo, Matt Devalaraja, Patrizia Pizzini, Claudia Torino, Daniela Leonardis, Sebastiano Cutrupi, Giovanni Tripepi, Francesca Mallamaci, Carmine Zoccali
Format: Article
Language:English
Published: MDPI AG 2019-04-01
Series:Journal of Clinical Medicine
Subjects:
erythroferrone
chronic kidney disease
dialysis
mortality
iron
Online Access:https://www.mdpi.com/2077-0383/8/4/523

Similar Items

Similar Items